MARKET

BLRX

BLRX

BioLine RX
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.410
-0.070
-2.84%
Closed 16:00 01/29 EST
OPEN
2.480
PREV CLOSE
2.480
HIGH
2.530
LOW
2.390
VOLUME
20.16K
TURNOVER
--
52 WEEK HIGH
13.05
52 WEEK LOW
1.550
MARKET CAP
23.62M
P/E (TTM)
-1.0023
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BLRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BLRX News

  • BioLineRx Concludes Recruitment in Pancreatic Cancer Study
  • Zacks.6d ago
  • BioLineRx completes enrollment in mid-stage BL-8040 study
  • seekingalpha.01/22 18:13
  • BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer
  • PR Newswire.01/22 12:00
  • BioLineRx's Pancreatic Cancer Drug Gets Orphan Drug Tag in EU
  • Zacks.01/15 14:56

More

Industry

Biotechnology & Medical Research
-0.30%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About BLRX

BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in schizophrenia patients; BL-1040, which is under pivotal CE-Mark registration trial for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, which has completed Phase I/II clinical trials for non-surgical removal of skin lesions; BL-1021 that has completed Phase Ia clinical trial for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is in Phase II clinical trial for the treatment of inflammatory bowel disease. The Company also has 11 pre-clinical stage development products for various indications.
More

Webull offers BioLineRX Ltd. (BLRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.